3D modelling

#3D imaging #3D modelling #Cell Science #Drug discovery #eBook #Live cell analysis #Oncology #Spheroid

eBook: Unlock the full potential of spheroid models in research

3D spheroid models and live-cell analysis are powerful tools transforming drug discovery and cancer science. Download this eBook ‘Exploring the Versatility of Using 3D Spheroid Models in Research‘ from Sartorius to learn: How real-time imaging unlocks deeper insights Discover why 3D models outperform traditional cultures How to create more… Read More

#News

#3D imaging #3D modelling #Cell Science #Drug discovery #eBook #Live cell analysis #Oncology #Spheroid

Go beyond 2D – Unlock the full potential of spheroid models in research

3D spheroid models and live-cell analysis – powerful tools transforming drug discovery and cancer science! Download the eBook to learn: How real-time imaging unlocks deeper insights Discover why 3D models outperform traditional cultures How to create more reliable, clinically relevant cancer models Download now and accelerate your breakthroughs.  … Read More

#eBooks #Resources

#3D modelling #Career #Interview #Meet the Researcher #Oncology #Pancreatic cancer

Meet the researcher: Catherine Whittington, Associate Professor

DDW’s Diana Turner speaks to Catherine Whittington, Associate Professor in the Department of Biomedical Engineering at WPI about her current work and the research that drives her.   DT: Can you tell us what you do and what you’re working on at the moment? CW: I teach classes in the biomedical… Read More

#Exclusive Content

Human heart
#3D modelling #Cell Science #Drug discovery #Drug toxicity #High throughput screening #Screening #Webinar

Last chance: The benefits of 3D cardiac microtissue models

Balancing assay throughput with physiological relevance is essential for improving disease modelling and compound screening in preclinical drug development. Induced pluripotent stem cell (iPSC) technology has revolutionised early drug discovery by integrating human biology, enhancing predictions of drug safety and efficacy. However, achieving both scalability and consistency in… Read More

Webinar date:
Supported by Ncardia
#News

#3D modelling #Cell Science #Drug discovery #Drug toxicity #High throughput screening #Screening #Webinar

Webinar: Advancing cardiotoxicity studies with 3D models

Balancing assay throughput with physiological relevance is essential for improving disease modelling and compound screening in preclinical drug development. Induced pluripotent stem cell (iPSC) technology has revolutionised early drug discovery by integrating human biology, enhancing predictions of drug safety and efficacy. However, achieving both scalability and consistency in… Read More

Webinar date:
Supported by Ncardia
#News

Heart
#3D modelling #Cell Science #Drug discovery #Drug toxicity #High throughput screening #Screening #Webinar

Webinar: Cardiac screening with physiologically relevant 3D models

Balancing assay throughput with physiological relevance is essential for improving disease modelling and compound screening in preclinical drug development. Induced pluripotent stem cell (iPSC) technology has revolutionised early drug discovery by integrating human biology, enhancing predictions of drug safety and efficacy. However, achieving both scalability and consistency in… Read More

Webinar date:
Supported by Ncardia
#News

Cardiovascular system
#3D modelling #Cell Science #Drug discovery #Drug toxicity #High throughput screening #Screening #Webinar

Webinar: How can 3D cardiac models advance drug screening?

Balancing assay throughput with physiological relevance is essential for improving disease modelling and compound screening in preclinical drug development. Induced pluripotent stem cell (iPSC) technology has revolutionised early drug discovery by integrating human biology, enhancing predictions of drug safety and efficacy. However, achieving both scalability and consistency in… Read More

Webinar date:
Supported by Ncardia
#News

Human heart
#3D modelling #Cell Science #Drug discovery #Drug toxicity #High throughput screening #Screening #Webinar

Watch now: Streamline high-throughput cardiac screening

Balancing assay throughput with physiological relevance is essential for improving disease modelling and compound screening in preclinical drug development. Induced pluripotent stem cell (iPSC) technology has revolutionised early drug discovery by integrating human biology, enhancing predictions of drug safety and efficacy. However, achieving both scalability and consistency in… Read More

Webinar date:
Supported by Ncardia
#News

#3D modelling #Artificial intelligence (AI) #European Commission #Monoclonal antibodies #Oncology #Solid tumours

This week in drug discovery (7-11 April) 

News round-up for 7-11 April by DDW Senior Digital Content Editor Diana Spencer. As the political news brings more uncertainty for the sector, this week we are focusing on positive developments in the field of oncology, from the possibilities of cancer cures in the rainforest, to a new… Read More

#News

#3D modelling #Cell Science #Drug discovery #Drug toxicity #High throughput screening #Screening #Webinar

Webinar: Advancing high-throughput cardiac screening

Balancing assay throughput with physiological relevance is essential for improving disease modelling and compound screening in preclinical drug development. Induced pluripotent stem cell (iPSC) technology has revolutionised early drug discovery by integrating human biology, enhancing predictions of drug safety and efficacy. However, achieving both scalability and consistency in… Read More

Webinar date:
Supported by Ncardia
#News

#3D modelling #Cell Science #Drug discovery #Drug toxicity #High throughput screening #Screening

Advancing high-throughput cardiac screening with physiologically relevant 3D iPSC-based models

Balancing assay throughput with physiological relevance is essential for improving disease modelling and compound screening in preclinical drug development. Induced pluripotent stem cell (iPSC) technology has revolutionised early drug discovery by integrating human biology, enhancing predictions of drug safety and efficacy. However, achieving both scalability and consistency in high-throughput applications… Read More

Webinar date:
Supported by Ncardia
#Webinars

Scientist working in the lab
#3D cell culture #3D modelling #ADME / Tox #Drug toxicity #Pharmokinetics #Webinar

Last chance: Optimise ADME/Tox testing with advanced cell models

Join DDW and Lonza for this free event ‘Building advanced cell models for toxicity testing’. The event will take place on 19 September at 3pm GMT / 4pm CET / 10am EST / 7am PST. Life sciences researchers need a host… Read More

Webinar date:
Supported by Lonza
#News

Medical research
#3D cell culture #3D modelling #ADME / Tox #Drug toxicity #Pharmokinetics #Webinar

Building advanced cell models for toxicity testing: Register today

Join DDW and Lonza for this free event ‘Building advanced cell models for toxicity testing’. The event will take place on 19 September at 3pm GMT / 4pm CET / 10am EST / 7am PST. Life sciences researchers need a host… Read More

Webinar date:
Supported by Lonza
#News

Biosafety testing
#3D cell culture #3D modelling #ADME / Tox #Drug toxicity #Pharmokinetics #Webinar

Free event: Next generation predictive in vitro ADMET solutions

Join DDW and Lonza for this free event ‘Building advanced cell models for toxicity testing’. The event will take place on 19 September at 3pm GMT / 4pm CET / 10am EST / 7am PST. Life sciences researchers need a host… Read More

Webinar date:
Supported by Lonza
#News

Researcher in a medical lab
#3D cell culture #3D modelling #ADME / Tox #Drug toxicity #Pharmokinetics #Webinar

Webinar: Create advanced predictive models for tox testing

Join DDW and Lonza for this free event ‘Building advanced cell models for toxicity testing’. The event will take place on 19 September at 3pm GMT / 4pm CET / 10am EST / 7am PST. Life sciences researchers need a host… Read More

Webinar date:
Supported by Lonza
#News